Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane E Angermann

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
The Lancet. Global Health|July 26, 2020
Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort studyJasper Tromp, Sahiddah Bamadhaj, John G F Cleland, et al.
JAMA Cardiology|January 9, 2020
Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart FailureGerasimos Filippatos, Christiane E Angermann, John G F Cleland, et al.
ESC Heart Failure|September 9, 2023
Prevalence of anti-beta-1 antibody 6 months after hospitalization for acute heart failure predicts adverse outcomeCaroline Morbach, Niklas Beyersdorf, Nicola Moser, et al.
ESC Heart Failure|November 5, 2021
Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoringMichael Böhm, Birgit Assmus, Stefan D Anker, et al.
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
The Lancet. Global Health|February 23, 2020
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort studyJasper Tromp, Sahiddah Bamadhaj, John G F Cleland, et al.
JACC. Heart Failure|April 11, 2021
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HFJasper Tromp, Wouter Ouwerkerk, John G F Cleland, et al.
European Journal of Heart Failure|August 4, 2023
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
The Lancet. Global Health|July 26, 2020
Correction to: Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort studyJasper Tromp, Sahiddah Bamadhaj, John G F Cleland, et al.
JAMA Cardiology|January 9, 2020
Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart FailureGerasimos Filippatos, Christiane E Angermann, John G F Cleland, et al.
ESC Heart Failure|September 9, 2023
Prevalence of anti-beta-1 antibody 6 months after hospitalization for acute heart failure predicts adverse outcomeCaroline Morbach, Niklas Beyersdorf, Nicola Moser, et al.
ESC Heart Failure|November 5, 2021
Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoringMichael Böhm, Birgit Assmus, Stefan D Anker, et al.
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
The Lancet. Global Health|February 23, 2020
Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort studyJasper Tromp, Sahiddah Bamadhaj, John G F Cleland, et al.
JACC. Heart Failure|April 11, 2021
Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HFJasper Tromp, Wouter Ouwerkerk, John G F Cleland, et al.
European Journal of Heart Failure|August 4, 2023
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Pageof 14